IMPLICATIONS OF MEIGAN ON THE USE OF MEDICAL DEVICES

Implications of MEIGaN on the Use of Medical Devices

Implications of MEIGaN on the Use of Medical Devices

MEIGaN is an executive agency of the Ministry of Health and its main purpose is to protect public health by regulating medicines in the UK market. This is achieved through a licensing and inspections, which ensure that licensed medicinal products comply with internationally agreed standards of quality, safety and efficacy, and that these drugs are manufactured, stored and distributed in accordance with agreed standards of the European community, good manufacturing and distribution practices. This includes strict licensing and regulatory requirements in UK law to protect patients from possible hazards associated with bad practices - for example, the purchase of a suspect or counterfeit products / ingredients, poor storage conditions, without creating a "good faith" of suppliers and buyers, a lack of records account and avoid the deterioration of the drug.

The fight against counterfeit drugs has been recognized by the UK government as an important issue and is reflected as one of the key objectives MEIGaN. While the UK legitimate pharmaceutical supply chain is tightly regulated and has one of the best international records for being difficult to penetrate, and recognizes that no supply chain is impenetrable.

In the UK, an increase in the prevalence of counterfeit medicine using illicit supply routes since 2000 and entry into the legal supply chain since 2004. This is consistent with the rest of the developed world. There have been no deaths from fake drugs in the UK. If it were not fake medicine case in Britain, which caused significant damage or death, it is likely that this would be to discover how it would affect many patients. In the same way that an outbreak of food poisoning were found to indicators that ...